These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 20853058)

  • 1. Single-center long-term follow-up after intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage x-rays.
    Blank E; Kraus-Tiefenbacher U; Welzel G; Keller A; Bohrer M; Sütterlin M; Wenz F
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():352-8. PubMed ID: 20853058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life after breast-conserving surgery and intraoperative radiotherapy for breast cancer using low-kilovoltage X-rays.
    Welzel G; Hofmann F; Blank E; Kraus-Tiefenbacher U; Hermann B; Sütterlin M; Wenz F
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():359-67. PubMed ID: 20853059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiotherapy for the rest of the breast as a prerequisite for limited surgery?].
    Wannenmacher M; von Fournier D; Anton HW
    Chirurg; 1992 Jun; 63(6):491-4. PubMed ID: 1643986
    [No Abstract]   [Full Text] [Related]  

  • 4. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
    Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
    Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity.
    Kraus-Tiefenbacher U; Bauer L; Kehrer T; Hermann B; Melchert F; Wenz F
    Onkologie; 2006 Mar; 29(3):77-82. PubMed ID: 16514267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage X-rays: the first 5 years of experience with a novel approach.
    Wenz F; Welzel G; Blank E; Hermann B; Steil V; Sütterlin M; Kraus-Tiefenbacher U
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1309-14. PubMed ID: 20100643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.
    Olson TP; Harter J; Muñoz A; Mahvi DM; Breslin T
    Ann Surg Oncol; 2007 Oct; 14(10):2953-60. PubMed ID: 17674109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost.
    Vaidya JS; Baum M; Tobias JS; Massarut S; Wenz F; Murphy O; Hilaris B; Houghton J; Saunders C; Corica T; Roncadin M; Kraus-Tiefenbacher U; Melchaert F; Keshtgar M; Sainsbury R; Douek M; Harrison E; Thompson A; Joseph D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1335-8. PubMed ID: 17084562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update).
    Holmes DR; Baum M; Joseph D
    Am J Surg; 2007 Oct; 194(4):507-10. PubMed ID: 17826067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative radiotherapy (IORT) with 50-kv X-ray machines as boost in breast cancer -- more questions than answers.
    Strnad V
    Onkologie; 2006 Mar; 29(3):73-5. PubMed ID: 16514266
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant hypofractionated radiotherapy with weekly concomitant boost for women with early breast cancer: the clinical experience at Genoa university.
    Corvò R; Ricchetti F; Doino D; Torielli P; Agostinelli S; Cavagnetto F; Giannelli F; D'Alonzo A; Vagge S; Belgioia L; Guenzi M
    Anticancer Res; 2010 Nov; 30(11):4749-53. PubMed ID: 21115935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.
    Sautter-Bihl ML; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sedlmayer F; Souchon R; Wenz F; Sauer R; ;
    Strahlenther Onkol; 2007 Dec; 183(12):661-6. PubMed ID: 18040609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?
    Yerushalmi R; Sulkes A; Mishaeli M; Neumann A; Dinerman M; Sulkes J; Rizel S; Yarom N; Gutman H; Fenig E
    Neoplasma; 2006; 53(6):507-10. PubMed ID: 17167720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative seroma formation after intraoperative radiotherapy using low-kilovoltage X-rays given during breast-conserving surgery.
    Kraus-Tiefenbacher U; Welzel G; Brade J; Hermann B; Siebenlist K; Wasser KS; Schneider FS; Sütterlin M; Wenz F
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1140-5. PubMed ID: 19836152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolate local failure after breast-conserving treatment for early breast cancer, about 57 cases.
    Deniaud-Alexandre E; Lauratet B; Lefranc JP; Genestié C; Lerouge D; Moureau-Zabotto L; Touboul E
    Cancer Radiother; 2004 Apr; 8(2):95-107. PubMed ID: 15063877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial.
    Bartelink H; Horiot JC; Poortmans PM; Struikmans H; Van den Bogaert W; Fourquet A; Jager JJ; Hoogenraad WJ; Oei SB; Wárlám-Rodenhuis CC; Pierart M; Collette L
    J Clin Oncol; 2007 Aug; 25(22):3259-65. PubMed ID: 17577015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial.
    Poortmans PM; Collette L; Bartelink H; Struikmans H; Van den Bogaert WF; Fourquet A; Jager JJ; Hoogenraad W; Müller RP; Dubois JB; Bolla M; Van Der Hulst M; Wárlám-Rodenhuis CC; Pierart M; Horiot JC;
    Cancer Radiother; 2008 Nov; 12(6-7):565-70. PubMed ID: 18760649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results.
    Lemanski C; Azria D; Thezenas S; Gutowski M; Saint-Aubert B; Rouanet P; Fenoglietto P; Ailleres N; Dubois JB
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1410-5. PubMed ID: 16442241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
    Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.